Found: 7
Select item for more details and to access through your institution.
Avacincaptad pegol in geographic atrophy secondary to age-related macular degeneration: a profile of its use.
- Published in:
- Drugs & Therapy Perspectives, 2024, v. 40, n. 8, p. 293, doi. 10.1007/s40267-024-01097-2
- By:
- Publication type:
- Article
Treat atopic dermatitis during pregnancy with safe and effective therapies.
- Published in:
- Drugs & Therapy Perspectives, 2024, v. 40, n. 8, p. 300, doi. 10.1007/s40267-024-01088-3
- By:
- Publication type:
- Article
Screen high-risk paediatric patients for non-infectious uveitis and consider its treatment options.
- Published in:
- Drugs & Therapy Perspectives, 2024, v. 40, n. 8, p. 304, doi. 10.1007/s40267-024-01091-8
- By:
- Publication type:
- Article
Corticosteroids are still first-line therapies for bullous pemphigoid, with biologics finding use in difficult-to-treat disease.
- Published in:
- Drugs & Therapy Perspectives, 2024, v. 40, n. 8, p. 310, doi. 10.1007/s40267-024-01085-6
- By:
- Publication type:
- Article
Adis summary of research: Omalizumab in severe asthma: effect on oral corticosteroid exposure and remodelling. A randomized open-label parallel study.
- Published in:
- Drugs & Therapy Perspectives, 2024, v. 40, n. 8, p. 291, doi. 10.1007/s40267-024-01083-8
- By:
- Publication type:
- Article
Glucocorticoid-induced osteoporosis—from molecular mechanism to clinical practice.
- Published in:
- Drugs & Therapy Perspectives, 2024, v. 40, n. 8, p. 315, doi. 10.1007/s40267-024-01079-4
- By:
- Publication type:
- Article
Evaluation of the Med Safety mobile app for reporting adverse events in Burkina Faso.
- Published in:
- Drugs & Therapy Perspectives, 2024, v. 40, n. 8, p. 330, doi. 10.1007/s40267-024-01078-5
- By:
- Publication type:
- Article